FDA recall, , Low risk
LifeServe Blood Center Apheresis Red Blood Cells, Leukocytes Reduced
Apheresis Red Blood Cells, Leukocytes Reduced were manufactured with an unknown quantity of additive solution.
Recall ended Jul 8, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
LifeServe Blood Center recalled Apheresis Red Blood Cells, Leukocytes Reduced because the cells were manufactured with an unknown quantity of additive solution. The recall began July 3, 2024, and was added to the FDA's Enforcement Report on July 8, 2026. The product was distributed in Iowa.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Apheresis Red Blood Cells, Leukocytes Reduced
Recall details
- Company began the recall
- Sold in
- Company
- LifeServe Blood Center
- Risk
Low risk
Taking it is unlikely to cause health problems.
FDA Class III recall · How risk is rated
- Event ID
- 99363
- Recall number
- B-0148-2026
All recalls from LifeServe Blood Center
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
Archived
